NCT00405067View on ClinicalTrials.gov

The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Hypercholesterolemia
Interventions
DRUG

BMS-201038 (AEGR-733)

DRUG

Ezetimibe

Trial Locations (1)

08540-6242

Pharmanet, Inc, Princeton

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT00405067 - The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia | Biotech Hunter | Biotech Hunter